Validity and reliability of the Patient-Reported Arthralgia Inventory: validation of a newly-developed survey instrument to measure arthralgia

Liana D Castel,1 Kenneth A Wallston,2 Benjamin R Saville,3 JoAnn R Alvarez,3 Bradley D Shields,4 Irene D Feurer,3 David Cella5 1Meharry-Vanderbilt Alliance, Nashville, TN, USA; 2Psychology in Nursing, Vanderbilt University School of Nursing, Nashville, TN, USA; 3Surgery and Biostatistics, Vanderbilt...

Full description

Bibliographic Details
Main Authors: Castel LD, Wallston KA, Saville BR, Alvarez JR, Shields BD, Feurer ID, Cella DF
Format: Article
Language:English
Published: Dove Medical Press 2015-07-01
Series:Patient Related Outcome Measures
Online Access:http://www.dovepress.com/validity-and-reliability-of-the-patient-reported-arthralgia-inventory--peer-reviewed-article-PROM
_version_ 1818107942507905024
author Castel LD
Wallston KA
Saville BR
Alvarez JR
Shields BD
Feurer ID
Cella DF
author_facet Castel LD
Wallston KA
Saville BR
Alvarez JR
Shields BD
Feurer ID
Cella DF
author_sort Castel LD
collection DOAJ
description Liana D Castel,1 Kenneth A Wallston,2 Benjamin R Saville,3 JoAnn R Alvarez,3 Bradley D Shields,4 Irene D Feurer,3 David Cella5 1Meharry-Vanderbilt Alliance, Nashville, TN, USA; 2Psychology in Nursing, Vanderbilt University School of Nursing, Nashville, TN, USA; 3Surgery and Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA; 4Medical Sciences, University of Arkansas School of Medicine, Little Rock, AR, USA; 5Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA Background: There is a need for a survey instrument to measure arthralgia (joint pain) that has been psychometrically validated in the context of existing reference instruments. We developed the 16-item Patient-Reported Arthralgia Inventory (PRAI) to measure arthralgia severity in 16 joints, in the context of a longitudinal cohort study to assess aromatase inhibitor-associated arthralgia in breast cancer survivors and arthralgia in postmenopausal women without breast cancer. We sought to evaluate the reliability and validity of the PRAI instrument in these populations, as well as to examine the relationship of patient-reported morning stiffness and arthralgia. Methods: We administered the PRAI on paper in 294 women (94 initiating aromatase inhibitor therapy and 200 postmenopausal women without breast cancer) at weeks 0, 2, 4, 6, 8, 12, 16, and 52, as well as once in 36 women who had taken but were no longer taking aromatase inhibitor therapy. Results: Cronbach's alpha was 0.9 for internal consistency of the PRAI. Intraclass correlation coefficients of test-retest reliability were in the range of 0.87–0.96 over repeated PRAI administrations; arthralgia severity was higher in the non-cancer group at baseline than at subsequent assessments. Women with joint comorbidities tended to have higher PRAI scores than those without (estimated difference in mean scores: -0.3, 95% confidence interval [CI] -0.5, -0.2; P<0.001). The PRAI was highly correlated with the Functional Assessment of Cancer Therapy-Endocrine Subscale item “I have pain in my joints” (reference instrument; Spearman r range: 0.76–0.82). Greater arthralgia severity on the PRAI was also related to decreased physical function (r=-0.47, 95% CI -0.55, -0.37; P<0.001), higher pain interference (r=0.65, 95% CI 0.57–0.72; P<0.001), less active performance status (estimated difference in location (-0.6, 95% CI -0.9, -0.4; P<0.001), and increased morning stiffness duration (r=0.62, 95% CI 0.54–0.69; P<0.0001). Conclusion: We conclude that the psychometric properties of the PRAI are satisfactory for measuring arthralgia severity. Keywords: arthralgia, joint pain, pain measurement, validation studies, questionnaire design, aromatase inhibitors, postmenopause
first_indexed 2024-12-11T02:07:29Z
format Article
id doaj.art-49a204c4089448028d2edecdd9390283
institution Directory Open Access Journal
issn 1179-271X
language English
last_indexed 2024-12-11T02:07:29Z
publishDate 2015-07-01
publisher Dove Medical Press
record_format Article
series Patient Related Outcome Measures
spelling doaj.art-49a204c4089448028d2edecdd93902832022-12-22T01:24:20ZengDove Medical PressPatient Related Outcome Measures1179-271X2015-07-012015default20521422824Validity and reliability of the Patient-Reported Arthralgia Inventory: validation of a newly-developed survey instrument to measure arthralgiaCastel LDWallston KASaville BRAlvarez JRShields BDFeurer IDCella DFLiana D Castel,1 Kenneth A Wallston,2 Benjamin R Saville,3 JoAnn R Alvarez,3 Bradley D Shields,4 Irene D Feurer,3 David Cella5 1Meharry-Vanderbilt Alliance, Nashville, TN, USA; 2Psychology in Nursing, Vanderbilt University School of Nursing, Nashville, TN, USA; 3Surgery and Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA; 4Medical Sciences, University of Arkansas School of Medicine, Little Rock, AR, USA; 5Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA Background: There is a need for a survey instrument to measure arthralgia (joint pain) that has been psychometrically validated in the context of existing reference instruments. We developed the 16-item Patient-Reported Arthralgia Inventory (PRAI) to measure arthralgia severity in 16 joints, in the context of a longitudinal cohort study to assess aromatase inhibitor-associated arthralgia in breast cancer survivors and arthralgia in postmenopausal women without breast cancer. We sought to evaluate the reliability and validity of the PRAI instrument in these populations, as well as to examine the relationship of patient-reported morning stiffness and arthralgia. Methods: We administered the PRAI on paper in 294 women (94 initiating aromatase inhibitor therapy and 200 postmenopausal women without breast cancer) at weeks 0, 2, 4, 6, 8, 12, 16, and 52, as well as once in 36 women who had taken but were no longer taking aromatase inhibitor therapy. Results: Cronbach's alpha was 0.9 for internal consistency of the PRAI. Intraclass correlation coefficients of test-retest reliability were in the range of 0.87–0.96 over repeated PRAI administrations; arthralgia severity was higher in the non-cancer group at baseline than at subsequent assessments. Women with joint comorbidities tended to have higher PRAI scores than those without (estimated difference in mean scores: -0.3, 95% confidence interval [CI] -0.5, -0.2; P<0.001). The PRAI was highly correlated with the Functional Assessment of Cancer Therapy-Endocrine Subscale item “I have pain in my joints” (reference instrument; Spearman r range: 0.76–0.82). Greater arthralgia severity on the PRAI was also related to decreased physical function (r=-0.47, 95% CI -0.55, -0.37; P<0.001), higher pain interference (r=0.65, 95% CI 0.57–0.72; P<0.001), less active performance status (estimated difference in location (-0.6, 95% CI -0.9, -0.4; P<0.001), and increased morning stiffness duration (r=0.62, 95% CI 0.54–0.69; P<0.0001). Conclusion: We conclude that the psychometric properties of the PRAI are satisfactory for measuring arthralgia severity. Keywords: arthralgia, joint pain, pain measurement, validation studies, questionnaire design, aromatase inhibitors, postmenopausehttp://www.dovepress.com/validity-and-reliability-of-the-patient-reported-arthralgia-inventory--peer-reviewed-article-PROM
spellingShingle Castel LD
Wallston KA
Saville BR
Alvarez JR
Shields BD
Feurer ID
Cella DF
Validity and reliability of the Patient-Reported Arthralgia Inventory: validation of a newly-developed survey instrument to measure arthralgia
Patient Related Outcome Measures
title Validity and reliability of the Patient-Reported Arthralgia Inventory: validation of a newly-developed survey instrument to measure arthralgia
title_full Validity and reliability of the Patient-Reported Arthralgia Inventory: validation of a newly-developed survey instrument to measure arthralgia
title_fullStr Validity and reliability of the Patient-Reported Arthralgia Inventory: validation of a newly-developed survey instrument to measure arthralgia
title_full_unstemmed Validity and reliability of the Patient-Reported Arthralgia Inventory: validation of a newly-developed survey instrument to measure arthralgia
title_short Validity and reliability of the Patient-Reported Arthralgia Inventory: validation of a newly-developed survey instrument to measure arthralgia
title_sort validity and reliability of the patient reported arthralgia inventory validation of a newly developed survey instrument to measure arthralgia
url http://www.dovepress.com/validity-and-reliability-of-the-patient-reported-arthralgia-inventory--peer-reviewed-article-PROM
work_keys_str_mv AT castelld validityandreliabilityofthepatientreportedarthralgiainventoryvalidationofanewlydevelopedsurveyinstrumenttomeasurearthralgia
AT wallstonka validityandreliabilityofthepatientreportedarthralgiainventoryvalidationofanewlydevelopedsurveyinstrumenttomeasurearthralgia
AT savillebr validityandreliabilityofthepatientreportedarthralgiainventoryvalidationofanewlydevelopedsurveyinstrumenttomeasurearthralgia
AT alvarezjr validityandreliabilityofthepatientreportedarthralgiainventoryvalidationofanewlydevelopedsurveyinstrumenttomeasurearthralgia
AT shieldsbd validityandreliabilityofthepatientreportedarthralgiainventoryvalidationofanewlydevelopedsurveyinstrumenttomeasurearthralgia
AT feurerid validityandreliabilityofthepatientreportedarthralgiainventoryvalidationofanewlydevelopedsurveyinstrumenttomeasurearthralgia
AT celladf validityandreliabilityofthepatientreportedarthralgiainventoryvalidationofanewlydevelopedsurveyinstrumenttomeasurearthralgia